Drug profile · INN
ex vivo expanded autologous human corneal epithelial cells containing stem cells
HOLOCLAR
- Patents linked
- 0
- News articles
- 0
Quick answer
ex vivo expanded autologous human corneal epithelial cells containing stem cells (HOLOCLAR) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN ex vivo expanded autologous human corneal epithelial cells containing stem cells
Brand HOLOCLAR
ATC code S01XA19
Frequently asked questions
What is ex vivo expanded autologous human corneal epithelial cells containing stem cells?
ex vivo expanded autologous human corneal epithelial cells containing stem cells (HOLOCLAR) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for ex vivo expanded autologous human corneal epithelial cells containing stem cells?
HOLOCLAR is a marketed brand name for ex vivo expanded autologous human corneal epithelial cells containing stem cells. Check FDA Drugs@FDA for the current US label holder and prescribing information.